Corpus Intelligence IC Memo — FORT HAMILTON HOSPITAL 2026-04-26 14:13 UTC
IC Memo — FORT HAMILTON HOSPITAL
Investment Committee Memorandum | OH | 138 beds | Grade C | EBITDA uplift $12.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

FORT HAMILTON HOSPITAL

CCN 360132 | BUTLER, OH | 138 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

FORT HAMILTON HOSPITAL is a 138-bed suburban community hospital in BUTLER, OH with $166.8M in net patient revenue and a -8.8% operating margin. The hospital serves a payer mix of 22.3% Medicare, 5.4% Medicaid, and 72.3% commercial.

Thesis: Undervalued. Our ML models identify $12.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.8% to -1.5% (+736bps).

Net Revenue HCRIS$166.8M
Current EBITDA COMPUTED$-14.7M
Operating Margin COMPUTED-8.8%
Occupancy HCRIS54.8%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS17.8%
Distress Probability ML45.9%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
92
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of -8.8% places it below the state median. Among 92 size-comparable peers (69-276 beds), the median margin is 0.2%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (69-276), prioritizing same-state peers. 92 hospitals in the comp set.

HospitalStateBedsRevenueMargin
FORT HAMILTON HOSPITAL (Target)OH138$166.8M-8.8%
RAINBOW BABIES & CHILDRENS HOSOH231$2.22B-5.0%
DAYTON CHILDRENS HOSPITALOH181$569.1M7.9%
MARIETTA MEMORIAL HOSPITALOH188$475.8M-12.4%
ADENA REGIONAL MEDICAL CENTEROH209$470.7M3.5%
SOUTHERN OHIO MEDICAL CENTEROH192$424.3M-4.9%
SOUTHWEST GENERAL HEALTH CENTEOH191$406.9M2.5%
MEDCENTRAL HEALTH SYSTEMOH240$382.6M0.2%
MARION GENERAL HOSPITALOH177$365.7M35.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $12.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.5M+210bp18mo
Cost to Collect4.5%2.5%$3.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.0M+122bp9mo
Clean Claim Rate88.0%96.0%$107K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.5M
Cost to Collect
$3.3M
Denial Rate Reduction
$3.3M
A/R Days Reduction
$2.0M
Clean Claim Rate
$107K
Total EBITDA Uplift$12.3M
Current EBITDA$-14.7M
+ RCM Uplift+$12.3M
Pro Forma EBITDA$-2.5M
Current Margin-8.8%
Pro Forma Margin-1.5%
WC Released (1x)$6.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-22.7M$25.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-22.7M$20.8M0.00x-100.0%
Bull Case9.0x11.0x$-20.4M$53.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-20.4M$52.8M0.00x-100.0%
Bear Case11.0x10.0x$-24.9M$-28.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-24.9M$-39.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 92 hospitals with 69-276 beds
  • Same-state prioritization (n=93)
  • Comp margins: P25=-12.3% / P50=0.2% / P75=7.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.